Benign Prostate Hyperplasia (BPH) is a condition that affects most men in their lifetimes

BPH is not prostate cancer. By the age of 50 years, approximately half of men have some symptoms of an enlarged prostate, and the rate increases with age. Traditionally men have been prescribed medications that relax or shrink the prostate, but recent research shows that waiting too long for a surgical procedure to treat BPH can lead to irreversible damage to the bladder, and sub-optimal outcomes from surgery. It seems that by the time men start to get symptoms of having to urinate urgently, frequently, or are getting up in the night to urinate, the bladder is sustaining permanent damage.

To learn more about BPH, follow this link:


There are now a range of options for surgically treating BPH better suited to individual men’s needs and priorities, beyond the traditional TURP procedure.

The HoLEP procedure requires specialised equipment and a degree of training and experience that means that it is not available in all centres. HoLEP has the best long-term outcomes of all of the BPH procedures in experienced hands. It can, however, be more rigorous than is required for men with less severe prostate symptoms.

To learn more about HoLEP, follow this link:


The Urolift procedure is a well-established minimally-invasive treatment for BPH. Urolift is not suited to all men, and in some cases a HoLEP procedure is more appropriate. Given the right prostate size, shape, and degree of symptoms, Urolift is an excellent procedure that causes a minimum of disruption to men’s lives. An overnight hospital stay is not required, irritating urinary symptoms are minimal and short lived, and Urolift is the only BPH procedure that has no impact on erectile or ejaculatory function, and if prostate cancer is diagnosed later in life, Urolift has no effect on future cancer surgery.

To learn more about Urolift, follow this link: